Clinical Study on a Novel Strategy of Individualized Non-Invasive Neuromodulation for the Treatment of Tic Disorders in Children

ConditionTic Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-18
SponsorShanghai Children's Medical Center

About this trial

This study aims to establish a novel personalized closed-loop NiBS/TMS therapeutic strategy and clinical protocol for children with Tic Disorders (TDs) through a series of scientific investigations. Additionally, it seeks to elucidate the underlying neural circuit mechanisms, enhance the therapeutic efficacy of TMS in pediatric TDs, and achieve precision neuromodulation for children with TDs.

Eligibility criteria

Qualifiers

1: Children and adolescents aged 5 to 18 years

Disqualifiers

1: WISC-R Full-Scale Intelligence Quotient (FIQ) <70

Trial design

Treatments tested in this trial

  • Transcranial Magnetic Stimulation
  • general behavioral therapy

Treatment groups

60 Participants
are divided into 2 treatment groups